Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases

NCT06620380 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT06620380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06620380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases
Lead sponsor
University of Zurich
Phase
Phase 2
Overall status
Recruiting
Start date
September 12, 2025
Completion date
June 30, 2027
Enrollment
102 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, brain metastases, adult